GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 87 filers reported holding GALENA BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,468,000 | +1246.8% | 4,191,527 | +1697.0% | 0.00% | – |
Q2 2016 | $109,000 | +98.2% | 233,252 | +476.8% | 0.00% | – |
Q1 2016 | $55,000 | -3.5% | 40,440 | +3.7% | 0.00% | – |
Q4 2015 | $57,000 | -64.2% | 38,995 | -61.3% | 0.00% | – |
Q3 2015 | $159,000 | +15.2% | 100,698 | +23.8% | 0.00% | – |
Q2 2015 | $138,000 | -47.3% | 81,332 | -56.8% | 0.00% | – |
Q1 2015 | $262,000 | -34.0% | 188,183 | -28.4% | 0.00% | – |
Q4 2014 | $397,000 | -38.6% | 262,829 | -16.3% | 0.00% | – |
Q3 2014 | $647,000 | -52.2% | 314,105 | -29.0% | 0.00% | – |
Q2 2014 | $1,353,000 | +229.2% | 442,296 | +169.0% | 0.00% | – |
Q1 2014 | $411,000 | -41.4% | 164,411 | +16.3% | 0.00% | – |
Q4 2013 | $701,000 | +100.9% | 141,355 | -7.8% | 0.00% | – |
Q3 2013 | $349,000 | -57.6% | 153,283 | -58.7% | 0.00% | – |
Q2 2013 | $823,000 | +1859.5% | 370,828 | +1361.3% | 0.00% | – |
Q2 2012 | $42,000 | -48.8% | 25,376 | -31.2% | 0.00% | – |
Q1 2012 | $82,000 | – | 36,862 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hoxton Financial, Inc. | 50,000 | $74,000 | 0.04% |
Alyeska Investment Group, L.P. | 1,593,277 | $2,342,000 | 0.02% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 31,000 | $46,000 | 0.02% |
GROUP ONE TRADING, L.P. | 1,346,904 | $1,980,000 | 0.02% |
Matisse Capital | 17,000 | $25,000 | 0.01% |
COMPTON CAPITAL MANAGEMENT INC /RI | 15,000 | $22,000 | 0.01% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 12,150 | $18,000 | 0.01% |
EQUITEC SPECIALISTS, LLC | 19,700 | $29,000 | 0.01% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 153,375 | $225,000 | 0.00% |
OPPENHEIMER & CO INC | 94,300 | $138,000 | 0.00% |